-
Zentalis Pharmaceuticals Announces Executive Leadership Changes Supporting Planned Registrational Clinical Studies of Azenosertib
13 Nov 2024 13:00 GMT
… Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and … the Board of Directors of AMAG Pharmaceuticals, where he led its … registrational studies of azenosertib; clinical development activities for azenosertib and …
-
Mapping vascular network architecture in primate brain using ferumoxytol-weighted laminar MRI
24 Jan 2025 16:05 GMT
… vital for diagnosing and addressing clinical deficits related to stroke, vascular … ) the intravascular ferumoxytol (Feraheme, ferumoxytol AMAG Pharmaceuticals Inc, Waltham, MA, USA) injection …
-
Comparative in vitro and in vivo Evaluation of Different Iron Oxide-Based Contrast Agents to Promote Clinical Translation in Compliance with Patient Safety
21 Apr 2023 01:47 GMT
… Germany) and Feraheme® from AMAG Pharmaceuticals (Waltham, USA).
Physicochemical Characterization … with physicochemical features and clinical information. J Control Release … for magnetic resonance imaging: clinical-translational experiences with ferumoxytol …
-
Global Intravenous (IV) Iron Drugs Market Report 2022: Clinical Trials, Industry Size, Share, Trends, Opportunities, and Forecasts, 2018-2028
28 Feb 2023 05:34 GMT
… global Intravenous iron drugs market.
AMAG pharmaceuticals, Inc.
Vifor Pharma Management … Inc.
Clinical Trial Analysis
Ongoing Clinical Trials
Completed Clinical Trials
Terminated Clinical Trials … -drugs-market-report-2022-clinical-trials-industry-size-share- …
-
AMAG Pharmaceuticals Files Submission in Response To the Food And Drug Administration’s Notice of Opportunity for a Hearing and Proposal To Withdraw Approval of Makena® (hydroxyprogesterone caproate injection)
14 Dec 2020 13:47 GMT
… 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. has submitted its … for preterm birth, including clinical study results that highlights … to the science and clinical experience supporting the … to discussing another randomized clinical trial, better focused …
-
AMAG Pharmaceuticals Requests Hearing to Maintain Makena® (Hydroxyprogesterone Caproate Injection) as a Treatment Option for Clinically Indicated Pregnant Patients
14 Oct 2020 20:11 GMT
… as their own long-standing clinical experience. The continued widening … contains forward-looking information about AMAG Pharmaceuticals, Inc. within the meaning … . AMAG Pharmaceuticals®, the logo and designs, are registered trademarks of AMAG Pharmaceuticals, …
-
AMAG Pharmaceuticals Provides Update on FDA’s Proposal Regarding Makena® (Hydroxyprogesterone Caproate Injection)
06 Oct 2020 01:05 GMT
… .” AMAG believes the totality of clinical data on Makena supports its … belief that the totality of clinical data on Makena supports its … statements. AMAG Pharmaceuticals®, the logo and designs, are registered trademarks of AMAG Pharmaceuticals, Inc …
-
AMAG Pharmaceuticals Provides Update on FDA's Proposal Regarding Makena(R) (Hydroxyprogesterone Caproate Injection)
06 Oct 2020 01:12 GMT
… ;
AMAG believes the totality of clinical data on Makena supports its … belief that the totality of clinical data on Makena supports its … statements.
AMAG Pharmaceuticals, the logo and designs, are registered trademarks of AMAG Pharmaceuticals, Inc …
-
AMAG Pharmaceuticals, Inc. (AMAG) CEO Scott Myers on Q2 2020 Results - Earnings Call Transcript
09 Aug 2020 08:48 GMT
… welcome everyone to the AMAG Pharmaceuticals Second Quarter 2020 Earnings … informative way to confirm clinical benefit. Our research … design utilized to confirm clinical benefit following the accelerated … COVID-related delays in clinical trial activities and …
-
AMAG Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Corporate Update
06 Aug 2020 11:00 GMT
… a global pause for various clinical research projects across therapeutic areas … COVID-19 related delays in clinical trials.
Selling, general and … lease liabilities
$
—
$
918
AMAG Pharmaceuticals, Inc.
Reconciliation of Condensed Consolidated …
About
© 1995-2025